Related Experiment Video
Updated: Apr 6, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor
1CASMU Arrhythmia Service, Montevideo, Uruguay; Department of Cardiology, British Hospital, Montevideo, Uruguay.
Insights
Predicting mortality in atrial fibrillation (AF) patients on warfarin is crucial. Combining the CHA2DS2VASc score with INR variability, particularly standard deviation of INR (SDINRs), offers superior prognostic value over CHA2DS2VASc alone.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Atrial fibrillation (AF) significantly increases mortality risk.
- Risk stratification is essential for managing AF patients.
- Oral anticoagulants like warfarin are vital but require careful monitoring.
Purpose of the Study:
- To compare the prognostic value of the CHA2DS2VASc score versus INR variability in predicting mortality in AF patients on warfarin.
- To evaluate the combined predictive power of CHA2DS2VASc and INR variability.
Main Methods:
- Observational study of 589 AF patients on warfarin for over 1 year.
- Calculation of CHA2DS2VASc, HAS-BLED, and SAMe-TT2R2 scores.
- Assessment of INR variability using time-in-therapeutic-range (TTR), %INRs in range, and standard deviation of INRs (SDINRs).
Main Results:
- Mean TTR was 53%, mean %INRs in range was 50.2%, and mean SDINRs was 0.84.
- 11.5% of patients died during the study period, with heart failure, bleeding, and ischemic stroke as primary causes.
- Patient survival correlated with TTR, %INRs in range, SDINRs, left ventricular ejection fraction, CHA2DS2VASc, and the combination of CHA2DS2VASc + SDINRs.
Conclusions:
- INR variability is a valuable tool for assessing anticoagulation quality.
- Combining CHA2DS2VASc and INR variability (especially SDINRs) enhances mortality prediction in warfarin-treated AF patients.
- SDINRs is a strong predictor of mortality compared to other INR variability metrics.
Background:
As atrial fibrillation (AF) carries twice the mortality hazard when compared with a similar population without diagnosed AF, the importance of risk stratifying is obvious. Several variables are related to outcome: age, comorbidities, and use of several medications, particularly oral anticoagulants. The CHA2DS2VASc score is an extremely useful tool to predict thromboembolic events and also mortality. The international normalized ratio (INR) variability is a treatment efficacy variable also associated with morbidity in patients receiving warfarin. The objective of the study is to compare the prognostic value of the CHA2DS2VASc versus the INR variability or its combination to predict mortality.
Methods:
In this observational study, we analyzed 589 patients from our Atrial Fibrillation Cohort, all on warfarin for more than 1 year and had more than 5 INRs performed in the last 2 years. The CHA2DS2VASc, HAS-BLED, and SAMe-TT2R2 scores were calculated as well as the INR variability using the time-in-therapeutic-range (TTR), the percentage of INRs (%INRs) within range, and the standard deviation of the INRs (SDINRs). Kaplan-Meier survival curves were plotted via different cutoff points.
Results:
The mean TTR was 53 ± 23%; 34.6% of the patients had a TTR above 64%. The mean %INRs in range was 50.2 ± 20.2; 17.3% of the population had %INRs in range above 70%. The mean SDINRs was .84 ± .54, and 38.4% had SDINRs below .79. Of 598, 139 (22%) discontinued warfarin treatment. Death was responsible for almost 50% of treatment discontinuation. Of 598, 68 patients died during the study period (11.5 %); the most frequent causes of death were heart failure (30%), bleeding (17%), and ischemic stroke (15%). Patient survival had a correlation with TTR, %INRs in range, SDINRs, left ventricular ejection fraction, CHA2DS2VASc, and the combination of CHA2DS2VASc + SDINRs (cutoff >1 and >.79, respectively).
Conclusions:
INR variability is an extremely useful tool to assess anticoagulation quality. Calculation of both CHA2DS2VASc and INR variability appears to be extremely useful to predict mortality in patients with AF receiving warfarin. The SDINRs emerges as a strong mortality predictor compared to the other INR variability indexes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Relative Risk
Drug Product Performance: In Vitro–In Vivo Correlation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

